O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-5.92%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.16B
AUM Growth
+$4.16B
(-14%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
48.04%
Holding
122
New
11
Increased
15
Reduced
22
Closed
16
Top Buys
| 1 |
Pfizer
PFE
|
$97.6M |
| 2 |
Axsome Therapeutics
AXSM
|
$45.1M |
| 3 |
SION
Sionna Therapeutics, Inc. Common Stock
SION
|
$38.8M |
| 4 |
UnitedHealth
UNH
|
$36.8M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$33.6M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$117M |
| 2 |
Merck
MRK
|
$82.6M |
| 3 |
Biogen
BIIB
|
$77.9M |
| 4 |
Intuitive Surgical
ISRG
|
$54.8M |
| 5 |
Universal Health Services
UHS
|
$48.3M |
Sector Composition
| 1 | Healthcare | 99.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
76
ImageneBio, Inc. Common Stock
IMA
$153M
| $4.53M | 0.11% |
3,539,358
| – | – |
|
77
Krystal Biotech
KRYS
$4.35B
| $4.24M | 0.1% |
23,500
| – | – |
|
78
enGene Holdings
ENGN
$249M
| $3.99M | 0.1% |
891,616
-28,723
| -3% | -$129K |
|
79
Oric Pharmaceuticals
ORIC
$1.03B
| $3.91M | 0.09% |
+700,000
| New | +$3.91M |
|
|
BCAX
80
Bicara Therapeutics Inc. Common Stock
BCAX
$655M
| $3.89M | 0.09% |
298,301
| – | – |
|
81
Q32 Bio
QTTB
$20.9M
| $3.72M | 0.09% |
2,252,987
| – | – |
|
|
BIOA
82
BioAge Labs, Inc. Common Stock
BIOA
$170M
| $3.47M | 0.08% |
921,959
| – | – |
|
83
Repare Therapeutics
RPTX
$73.9M
| $3.28M | 0.08% |
3,322,488
| – | – |
|
84
Passage Bio
PASG
$22.7M
| $2.48M | 0.06% |
7,034,626
-370,243
| -5% | -$131K |
|
85
Insmed
INSM
$30.3B
| $2.19M | 0.05% |
28,659
-65,900
| -70% | -$5.03M |
|
|
CBLL
86
CeriBell, Inc. Common Stock
CBLL
$426M
| $2.16M | 0.05% |
112,500
| – | – |
|
87
Instil Bio
TIL
$196M
| $2.03M | 0.05% |
116,785
| – | – |
|
|
CMMB
88
Chemomab Therapeutics
CMMB
$15.7M
| $1.9M | 0.05% |
1,741,273
| – | – |
|
89
Cardiff Oncology
CRDF
$130M
| $1.8M | 0.04% |
573,884
-964,578
| -63% | -$3.03M |
|
90
X4 Pharmaceuticals
XFOR
$70M
| $1.6M | 0.04% |
6,776,515
-357,000
| -5% | -$84.4K |
|
91
Nkarta
NKTX
$149M
| $1.51M | 0.04% |
821,400
| – | – |
|
92
Traws Pharma
TRAW
$11.4M
| $1.39M | 0.03% |
605,531
| – | – |
|
93
Fate Therapeutics
FATE
$115M
| $1.33M | 0.03% |
1,680,580
| – | – |
|
|
TSBX
94
DELISTED
Turnstone Biologics
TSBX
| $1.27M | 0.03% |
3,099,265
| – | – |
|
95
Amylyx Pharmaceuticals
AMLX
$877M
| $1.23M | 0.03% |
348,000
| – | – |
|
96
BiomX
PHGE
$14.1M
| $993K | 0.02% |
1,787,767
| – | – |
|
97
Kezar Life Sciences
KZR
$28.5M
| $940K | 0.02% |
192,700
| – | – |
|
98
Tango Therapeutics
TNGX
$745M
| $754K | 0.02% |
550,000
| – | – |
|
99
Invivyd
IVVD
$218M
| $565K | 0.01% |
933,500
-215,800
| -19% | -$131K |
|
100
Korro Bio
KRRO
$245M
| $564K | 0.01% |
32,400
| – | – |
|